APA

Balasa R., Maier S., Voidazan S., Hutanu A., Bajko Z., Motataianu A., Tilea B. & Tiu C. (20180209). Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response. : CNS & neurological disorders drug targets.

Chicago

Balasa Rodica, Maier Smaranda, Voidazan Septimiu, Hutanu Adina, Bajko Zoltan, Motataianu Anca, Tilea Brandusa and Tiu Cristina. 20180209. Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response. : CNS & neurological disorders drug targets.

Harvard

Balasa R., Maier S., Voidazan S., Hutanu A., Bajko Z., Motataianu A., Tilea B. and Tiu C. (20180209). Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response. : CNS & neurological disorders drug targets.

MLA

Balasa Rodica, Maier Smaranda, Voidazan Septimiu, Hutanu Adina, Bajko Zoltan, Motataianu Anca, Tilea Brandusa and Tiu Cristina. Assessment of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-Beta1 Serum Titers in Relapsing Remitting Multiple Sclerosis Patients Treated with Avonex, Possible Biomarkers for Treatment Response. : CNS & neurological disorders drug targets. 20180209.